市場調查報告書
商品編碼
1411273
神經血栓切除裝置市場規模 - 按產品類型(支架回收器、抽吸裝置、圈套器、連續沖洗導管)、最終用途(醫院、診所、門診手術中心) - 全球預測(2024-2032)Neurothrombectomy Devices Market Size - By Product Type (Stent Retrievers, Aspiration Devices, Snares, Continuous Flush Catheter), End-use (Hospitals, Clinics, Ambulatory Surgical Centers) - Global Forecast (2024-2032) |
由於缺血性中風發生率不斷增加以及人口老化,神經血栓切除術設備市場規模預計從 2024 年到 2032 年CAGR為 7.3%。神經介入技術的不斷進步以及對及時有效的中風治療的更加重視將加速產品需求。
此外,人們對血管內手術益處的認知不斷提高,微創技術的採用也不斷增加。正在進行的研發活動正在推出具有增強安全性和功效的創新設備。例如,2021 年5 月,醫療器材公司Perflow Medical 宣布其Stream17 動態神經血栓切除術網路首次成功臨床應用,該網路專門設計用於有效解決解剖結構更複雜、患有出血性和缺血性中風的患者。將神經血栓切除術涵蓋標準中風護理方案以及醫療基礎設施的改善也將促進產業成長。
神經血栓切除術設備產業按產品類型、最終用途和地區分類。
根據產品類型,由於中風治療中擴大採用血管內手術,圈套器領域的產業價值預計從 2024 年到 2032 年將以 7.1% 的CAGR成長。圈套器在捕捉和清除血栓方面具有功效,有助於改善患者的治療效果。圈套器技術的不斷進步將進一步推動產品需求,以提供更高的安全性和有效性。
預計 2024 年至 2032 年,門診手術中心最終使用領域的神經血栓切除術設備產業佔有率複合CAGR為 7.5%。這是由於人們對微創神經血栓切除術的偏好不斷增加。門診手術中心提供便利、成本效益和更短的恢復時間,提高了患者和臨床醫生的接受度。此外,對門診護理的日益重視將進一步增加這些設施對神經血栓切除術設備的需求。
從地區來看,2023年至2032年,歐洲神經血栓切除設備市場預計複合CAGR為7.4%。這一成長可歸因於中風病例發病率的增加、人口老齡化的加劇以及神經介入技術的快速進步。對改善中風治療方案的日益重視以及醫療基礎設施的發展將推動區域市場的成長。
Neurothrombectomy devices market size is projected to register 7.3% CAGR from 2024 to 2032, due to the increasing incidences of ischemic strokes along with the growing aging population. The rising advancements in neurointerventional techniques and the higher emphasis on timely and effective stroke treatment will accelerate the product demand.
Additionally, the rising awareness of the benefits of endovascular procedures is escalating the adoption of minimally invasive techniques. The ongoing R&D activities are leading to the introduction of innovative devices with enhanced safety and efficacy profiles. For instance, in May 2021, Perflow Medical, a medical device company, announced the first successful clinical application of its Stream17 Dynamic Neurothrombectomy Net, specifically engineered to efficiently address patients with more complex anatomies experiencing both hemorrhagic and ischemic strokes. The integration of neurothrombectomy procedures into standard stroke care protocols and improvements in healthcare infrastructure will also boost the industry growth.
The neurothrombectomy devices industry is categorized into product type, end-use, and region.
Based on product type, the industry value from the snares segment is projected to rise at 7.1% CAGR from 2024 to 2032, owing to the increasing adoption for endovascular procedures in stroke treatment. Snares demonstrate efficacy in capturing and removing blood clots, contributing to improved patient outcomes. The increasing advancements in snare technologies will further fuel the product demand to offer enhanced safety and effectiveness.
Neurothrombectomy devices industry share from the ambulatory surgical centers end-use segment is estimated to witness 7.5% CAGR from 2024 to 2032. This is due to the rising preference for minimally invasive neurothrombectomy procedures. Ambulatory surgical centers offer convenience, cost-effectiveness, and shorter recovery times, driving patient and clinician acceptance. Moreover, the growing emphasis on outpatient care will further boost the demand for neurothrombectomy devices in these facilities.
Regionally, the Europe neurothrombectomy devices market is projected to expand at 7.4% CAGR from 2023 to 2032. The growth can be attributed to the increasing incidence of stroke cases, growing aging population, and rapid advancements in neurointerventional techniques. The surging emphasis on improving stroke treatment protocols coupled with healthcare infrastructure developments will drive the regional market growth.